文献速递神经核医学

在记忆门诊人群中,淀粉样蛋白负荷而非区域葡萄糖代谢可预测向阿尔茨海默病痴呆的转化

Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-03-15

研究在39例遗忘型轻度认知障碍(MCI)患者中比较[18F]FDG PET与[11C]PIB PET对向阿尔茨海默病(AD)痴呆转化的预测价值,患者来自单中心临床注册,随访2.7±1.2年。[18F]FDG PET未显著预测转化(p>0.1),而包含[11C]PIB PET的模型显著预测转化(p<0.05),[11C]PIB阳性者AD风险比为10.2(95%CI 1.3-78.1)。作者认为淀粉样蛋白PET应优先用于个体预测和患者咨询。

要点

  • 在39例MCI患者中,[18F]FDG PET未显著预测向AD痴呆的转化(p>0.1)。
  • [11C]PIB PET阳性者向AD转化的风险比为10.2(95%CI 1.3-78.1)。
  • 作者认为临床实践中应优先使用淀粉样蛋白PET进行个体预测和患者咨询。

核心结论

  • 与[11C]PIB PET不同,[18F]FDG PET在该临床患者样本中未预测从MCI向AD的转化。
  • 作者认为淀粉样蛋白PET应优先用于临床实践中的个体预测和患者咨询。

研究设计与样本

  • 从单中心临床注册中识别39例接受过[18F]FDG和[11C]PIB PET的MCI患者。
  • [18F]FDG和[11C]PIB PET图像分别被评定为AD典型区域低代谢和β-淀粉样蛋白沉积阳性或阴性,评定者对临床信息设盲。
  • PET后对患者进行2.7±1.2年的临床随访。
  • 采用校正年龄和性别的Cox比例风险模型检验[18F]FDG PET、[11C]PIB PET及两者联合的预测价值。

主要发现

  • [18F]FDG PET未显著预测向AD的转化(p>0.1)。
  • 仅包含[11C]PIB PET的模型显著预测向AD的转化(p<0.05)。
  • 同时包含[18F]FDG和[11C]PIB PET的模型显著预测向AD的转化(p<0.05)。
  • [11C]PIB扫描阳性的患者AD风险比为10.2(95%置信区间1.3-78.1)。
  • 使用AD典型区域归一化[18F]FDG摄取和[11C]PIB标准化摄取值比值作为连续预测变量的半定量分析证实了上述结果。

临床怎么用

  • 作者认为淀粉样蛋白PET应优先用于临床实践中的个体预测和患者咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The value of imaging regional glucose metabolism with [18F]FDG PET for the prediction of progression from mild cognitive impairment (MCI) to Alzheimer's dementia (AD) is controversial. The predictive value of imaging with [18F]FDG PET was therefore tested and compared with that of imaging beta-amyloid load with [11C]PIB PET in the same memory clinic population of MCI patients. METHODS: Thirty-nine patients with MCI who had undergone [18F]FDG as well as [11C]PIB PET were identified from a single-centre clinical registry. [18F]FDG and [11C]PIB PET images were rated as positive or negative for the presence of regional hypometabolism typical of AD and beta-amyloid deposition, respectively. Raters were blinded to the clinical information. Patients were followed clinically for 2.7 ± 1.2 years after PET. Cox proportional hazards models, adjusted for age and sex, were used to test the predictive value of [18F]FDG PET, [11C]PIB PET, and both in combination. RESULTS: [18F]FDG PET did not significantly predict conversion to AD (p > 0.1). By contrast, models including [11C]PIB PET only (p < 0.05) or both [18F]FDG and [11C]PIB PET (p < 0.05) significantly predicted conversion to AD. The hazard ratio for AD in patients with a positive [11C]PIB scan was 10.2 (95% confidence interval 1.3-78.1). The results were confirmed by analysis of semiquantitative measures using normalized [18F]FDG uptake and [11C]PIB standardized uptake value ratios in AD-typical regions as continuous predictors. CONCLUSION: In contrast to [11C]PIB PET, [18F]FDG PET did not predict conversion from MCI to AD in this clinical patient sample. Therefore, amyloid PET should be preferred for individual prediction and patient counselling in clinical practice.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Frings L, Hellwig S, Bormann T, et al. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population. Eur J Nucl Med Mol Imaging. 2018. PMID: 29546632. doi:10.1007/s00259-018-3983-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。